COVID-19 post-intensive care syndrome: Clinical Trials

2 unknown. 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	1	Unknown 1

Follow COVID-19 post-intensive care syndrome: new trials by email Literature Review of COVID-19 post-intensive care syndrome trials Research Report on COVID-19 post-intensive care syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Impact of Mental Health and Cognitive Disorders on Quality of Life in Severe Covid-19 Survivors Montreal cognitive assessment scale (MOCA) - COVID-19 Post-Intensive Care Syndrome		Unknown	Hospital Sao Domingos	65	2023-06-01	2023-05-03
COVID-19 Vaccination Detoxification in LDL-C Atorvastatin Calcium Tablets - COVID-19 Stress Syndrome, COVID-19 Vaccine Adverse Reaction	Phase 1	Unknown	Yang I. Pachankis	1	2023-05-01	2023-05-06

Narrower conditions

COVID-19 (2)  ·  Anxiety Disorders (1)  ·  COVID-19 stress syndrome (1)  ·  Cognitive Dysfunction (1)  ·  Depression (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Stress Disorders, Post-Traumatic (1)  ·  postintensive care syndrome (1)

Broader conditions

Coronaviridae Infections (2)  ·  Coronavirus Infections (2)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Nidovirales Infections (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Cognition Disorders (1)  ·  Immune System Diseases (1)

Interventions

Atorvastatin (1)

Sponsors

Hospital Sao Domingos (1)  ·  Yang I. Pachankis (1)

Countries

China (1)

Results publications

PMID 15817019, PMID 21946660, PMID 32835708, PMID 33049394, PMID 33169214, PMID 33428867, PMID 33729425, PMID 33730197, PMID 33753937, PMID 33769771, PMID 6880820, PMID 9243433